PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES
Autor: | Tee, M., Tee, C.A. |
---|---|
Zdroj: | In Value in Health October 2018 21 Supplement 3:S290-S291 |
Databáze: | ScienceDirect |
Externí odkaz: |